KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Depreciation & Amortization (CF) (2016 - 2025)

Travere Therapeutics' Depreciation & Amortization (CF) history spans 13 years, with the latest figure at $18.1 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 50.0% year-over-year to $18.1 million; the TTM value through Dec 2025 reached $60.7 million, up 39.46%, while the annual FY2025 figure was $60.7 million, 39.46% up from the prior year.
  • Depreciation & Amortization (CF) reached $18.1 million in Q4 2025 per TVTX's latest filing, up from $15.8 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $18.1 million in Q4 2025 to a low of -$7.8 million in Q4 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $8.8 million, with a median of $9.7 million recorded in 2023.
  • Peak YoY movement for Depreciation & Amortization (CF): crashed 217.91% in 2021, then skyrocketed 1547.04% in 2023.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at -$7.8 million in 2021, then skyrocketed by 180.71% to $6.3 million in 2022, then skyrocketed by 50.32% to $9.5 million in 2023, then rose by 27.43% to $12.1 million in 2024, then skyrocketed by 50.0% to $18.1 million in 2025.
  • Per Business Quant, the three most recent readings for TVTX's Depreciation & Amortization (CF) are $18.1 million (Q4 2025), $15.8 million (Q3 2025), and $14.0 million (Q2 2025).